Stay updated on Daratumumab with Bortezomib/Dexamethasone Clinical Trial

Sign up to get notified when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page has updated the status of a clinical trial to 'Unknown' and revised the version number from v2.16.4 to v2.16.5.
    Difference
    2%
    Check dated 2025-07-04T04:11:41.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.9%
    Check dated 2025-06-19T20:04:50.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:26:23.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T06:14:27.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T18:09:08.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page has undergone significant content changes regarding the treatment of newly diagnosed Multiple Myeloma patients, particularly focusing on the efficacy of Daratumumab in combination therapies. Key details about the AMN006 study and its inclusion and exclusion criteria have been added, while substantial information about previous treatment outcomes and the need for new therapies has been removed.
    Difference
    46%
    Check dated 2025-04-16T13:06:09.000Z thumbnail image

Stay in the know with updates to Daratumumab with Bortezomib/Dexamethasone Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab with Bortezomib/Dexamethasone Clinical Trial page.